JAGSONPAL PHARMACEUTICALS
Back to Income Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹209 Cr | ₹237 Cr | ₹218 Cr | ₹1,879 Cr | ₹159 Cr |
What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹209 Cr |
| Mar2024 | ₹237 Cr |
| Mar2023 | ₹218 Cr |
| Mar2022 | ₹1,879 Cr |
| Mar2021 | ₹159 Cr |
How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹209 Cr | -11.83 | |
| Mar2024 | ₹237 Cr | 8.79 | |
| Mar2023 | ₹218 Cr | -88.42 | |
| Mar2022 | ₹1,879 Cr | 1,085.27 | |
| Mar2021 | ₹159 Cr | - | |
Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,428.2 Cr | -10.2% | -7.8% | 42% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
| CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -10.2% |
-7.8% |
42% |
| SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses